FDA considers approving Pfizer vaccine booster shots

The FDA is considering authorizing Pfizer's COVID vaccine booster shot for those who are high-risk or 65 and older. It comes as the Delta variant surge appears to be peaking nationally, according to researchers advising the CDC. Nancy Chen has the latest.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting